[Skip to Content]
[Skip to Content Landing]
August 1965

Chemotherapy of Cancer.

Arch Intern Med. 1965;116(2):314-315. doi:10.1001/archinte.1965.03870020154039

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


The discipline of cancer chemotherapy has scarcely a decade and a half of postnatal life; nevertheless, numerous authors have already contributed to a sizeable verbal monument. This volume is a testimonial to the editor, Placidus A. Plaffner, who is research director of F. Hoffman-LaRoche and Co., Ltd.

The international character of the meeting is attested to by the presence of speakers from a number of different geographic regions. The United States is well represented, as are various drug companies; a Hoffman-LaRoche.ab" was "picked up" by Hoffman-LaRoche. This volume could represent an interim publication between meetings of the International Congress Against Cancer. Of interest is the fact that this book was published in the same calendar year as the meeting, at most seven months from its denouement.

The tempo of the meeting was initiated by David Karnofsky (US) who painted a retrospective and prospective picture of cancer chemotherapy orientation.

The manner of

First Page Preview View Large
First page PDF preview
First page PDF preview